We have only just started to understand how our brains clean themselves, but columnist Helen Thomson finds promising evidence ...

Based on the positive global Phase III MANEUVER study, the National Medical Products Administration (NMPA) has granted the ...

It may contain inaccuracies due to the limitations of machine translation. Korea Science Journalists Association-Institute for Basic Science (IBS) Science Media Academy Director Gou Young-Gou of the ...

Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...

Cognito Therapeutics, a clinical-stage medical device company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced the presentation of new CSF proteomic and ...

Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by inhibiting semaphorin 4D (SEMA4D) induced pathology in brain, ...

Researchers have discovered a brain enzyme that could lead to new treatments for neurodegenerative diseases by restoring ...

This article examines the biological complexity of chronic pain and highlights novel therapeutic strategies including ...

The Vancouver school board has voted to permanently close Sir Guy Carleton Elementary, which has been sitting vacant for ...

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

ROME, Italy, Dec. 10, 2025 /PRNewswire/ -- Fondazione Telethon announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Waskyra, an ex ...

An update from Gain Therapeutics ( ($GANX) ) is now available. On December 18, 2025, Gain Therapeutics reported exploratory endpoint data from ...